Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapy
The paper emphases the need for dual antihypertensive therapy and describes itsbenefits, such as synergetic hypotensive action and other beneficial effects. One ofthe pathogenetically justified variants of combination therapy – a third-generationdihydropyridine calcium channel antagonist and an angi...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2013-06-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/395 |
| _version_ | 1797857105483399168 |
|---|---|
| author | E. O. Taratukhin |
| author_facet | E. O. Taratukhin |
| author_sort | E. O. Taratukhin |
| collection | DOAJ |
| description | The paper emphases the need for dual antihypertensive therapy and describes itsbenefits, such as synergetic hypotensive action and other beneficial effects. One ofthe pathogenetically justified variants of combination therapy – a third-generationdihydropyridine calcium channel antagonist and an angiotensin-converting enzymeinhibitor – is discussed in more detail. |
| first_indexed | 2024-04-09T20:51:16Z |
| format | Article |
| id | doaj.art-ae6fada847a343d899ef0de979cf51c0 |
| institution | Directory Open Access Journal |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| last_indexed | 2024-04-09T20:51:16Z |
| publishDate | 2013-06-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj.art-ae6fada847a343d899ef0de979cf51c02023-03-29T21:23:20Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202013-06-010310010310.15829/1560-4071-2013-3-100-103395Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapyE. O. Taratukhin0N. I. Pirogov Russian National Medical Research University, Moscow, RussiaThe paper emphases the need for dual antihypertensive therapy and describes itsbenefits, such as synergetic hypotensive action and other beneficial effects. One ofthe pathogenetically justified variants of combination therapy – a third-generationdihydropyridine calcium channel antagonist and an angiotensin-converting enzymeinhibitor – is discussed in more detail.https://russjcardiol.elpub.ru/jour/article/view/395renninhypotensive effectlercanidipinecombination therapy |
| spellingShingle | E. O. Taratukhin Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapy Российский кардиологический журнал rennin hypotensive effect lercanidipine combination therapy |
| title | Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapy |
| title_full | Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapy |
| title_fullStr | Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapy |
| title_full_unstemmed | Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapy |
| title_short | Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapy |
| title_sort | arterial hypertension treatment with a calcium channel blocker and an ace inhibitor benefits of combination therapy |
| topic | rennin hypotensive effect lercanidipine combination therapy |
| url | https://russjcardiol.elpub.ru/jour/article/view/395 |
| work_keys_str_mv | AT eotaratukhin arterialhypertensiontreatmentwithacalciumchannelblockerandanaceinhibitorbenefitsofcombinationtherapy |